Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-country, Epidemiologic Study to Assess the Interferon Gamma Release Assay (IGRA) Positivity, and to Build Capacity to Conduct a Tuberculosis (TB) Vaccine Efficacy Study, in Populations With a High TB Disease Burden

NCT05190146 is registered in ClinicalTrials.gov with Gates Medical Research Institute as lead sponsor.

NCT NCT05190146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05190146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-country, Epidemiologic Study to Assess the Interferon Gamma Release Assay (IGRA) Positivity, and to Build Capacity to Conduct a Tuberculosis (TB) Vaccine Efficacy Study, in Populations With a High TB Disease Burden
Lead sponsor
Gates Medical Research Institute
Phase
Observational
Overall status
Completed
Start date
December 20, 2021
Completion date
August 16, 2024
Enrollment
7,203 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary